LTR Pharma Ltd

LTP

Company Profile

  • Business description

    LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.

  • Contact

    9A/204 Alice Street
    BrisbaneQLD4000
    AUS

    T: +61 1800519711

    https://www.ltrpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

Stocks News & Analysis

stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks

Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27

Charts from the Australian Dividend Outlook show the sectors where they are abundant.
stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,276.6019.90-0.21%
CAC 408,064.644.510.06%
DAX 4024,667.2570.120.29%
Dow JONES (US)46,601.781.20-0.00%
FTSE 1009,505.1343.74-0.46%
HKSE26,752.5976.87-0.29%
NASDAQ23,043.38255.021.12%
Nikkei 22548,580.44845.451.77%
NZX 50 Index13,570.862.380.02%
S&P 5006,753.7239.130.58%
S&P/ASX 2008,969.8025.20-0.28%
SSE Composite Index3,933.9751.201.32%

Market Movers